GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lannett Co Inc (OTCPK:LCINQ) » Definitions » Beneish M-Score

Lannett Co (Lannett Co) Beneish M-Score : -4.18 (As of Apr. 26, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Lannett Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.18 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Lannett Co's Beneish M-Score or its related term are showing as below:

LCINQ' s Beneish M-Score Range Over the Past 10 Years
Min: -5.8   Med: -2.57   Max: 3.11
Current: -4.18

During the past 13 years, the highest Beneish M-Score of Lannett Co was 3.11. The lowest was -5.80. And the median was -2.57.


Lannett Co Beneish M-Score Historical Data

The historical data trend for Lannett Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lannett Co Beneish M-Score Chart

Lannett Co Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.36 -3.16 -2.97 -3.66 -4.05

Lannett Co Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.28 -4.05 -3.95 -3.48 -4.18

Competitive Comparison of Lannett Co's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Lannett Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lannett Co's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lannett Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Lannett Co's Beneish M-Score falls into.



Lannett Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Lannett Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8072+0.528 * 0.8018+0.404 * 0.85+0.892 * 0.8342+0.115 * 0.3488
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.2669+4.679 * -0.178965-0.327 * 1.7761
=-4.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar23) TTM:Last Year (Mar22) TTM:
Total Receivables was $68.2 Mil.
Revenue was 80.507 + 80.894 + 75.079 + 74.189 = $310.7 Mil.
Gross Profit was 15.175 + 14.278 + 12.599 + 7.857 = $49.9 Mil.
Total Current Assets was $261.7 Mil.
Total Assets was $334.6 Mil.
Property, Plant and Equipment(Net PPE) was $21.5 Mil.
Depreciation, Depletion and Amortization(DDA) was $26.9 Mil.
Selling, General, & Admin. Expense(SGA) was $81.2 Mil.
Total Current Liabilities was $733.1 Mil.
Long-Term Debt & Capital Lease Obligation was $9.2 Mil.
Net Income was -101.47 + -36.308 + -28.019 + -93.295 = $-259.1 Mil.
Non Operating Income was -73.886 + -12.125 + -1.678 + -54.058 = $-141.7 Mil.
Cash Flow from Operations was -7.92 + -19.218 + -11.311 + -19.01 = $-57.5 Mil.
Total Receivables was $101.2 Mil.
Revenue was 78.357 + 86.508 + 101.525 + 106.009 = $372.4 Mil.
Gross Profit was 3.078 + 5.71 + 16.521 + 22.659 = $48.0 Mil.
Total Current Assets was $318.7 Mil.
Total Assets was $572.3 Mil.
Property, Plant and Equipment(Net PPE) was $150.1 Mil.
Depreciation, Depletion and Amortization(DDA) was $36.1 Mil.
Selling, General, & Admin. Expense(SGA) was $76.8 Mil.
Total Current Liabilities was $94.4 Mil.
Long-Term Debt & Capital Lease Obligation was $620.4 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(68.153 / 310.669) / (101.21 / 372.399)
=0.219375 / 0.271778
=0.8072

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(47.968 / 372.399) / (49.909 / 310.669)
=0.128808 / 0.16065
=0.8018

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (261.716 + 21.494) / 334.624) / (1 - (318.705 + 150.148) / 572.307)
=0.153647 / 0.180767
=0.85

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=310.669 / 372.399
=0.8342

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(36.138 / (36.138 + 150.148)) / (26.941 / (26.941 + 21.494))
=0.193992 / 0.55623
=0.3488

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(81.215 / 310.669) / (76.844 / 372.399)
=0.26142 / 0.206349
=1.2669

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((9.158 + 733.079) / 334.624) / ((620.365 + 94.355) / 572.307)
=2.218122 / 1.24884
=1.7761

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-259.092 - -141.747 - -57.459) / 334.624
=-0.178965

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Lannett Co has a M-score of -4.18 suggests that the company is unlikely to be a manipulator.


Lannett Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Lannett Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Lannett Co (Lannett Co) Business Description

Traded in Other Exchanges
N/A
Address
1150 Northbrook Drive, Suite 155, Trevose, PA, USA, 19053
Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products. It offers solid oral, extended-release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. In addition, the company also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory, and others. It operates in the segment of generic pharmaceuticals. Its customers include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others.
Executives
John C Chapman director 9000 STATE ROAD, PHILADELPHIA PA 19136
Timothy C Crew officer: Chief Executive Officer 9000 STATE ROAD, PHILADELPHIA PA 19136
Patrick G Lepore director 17-17 ROUTE 208 N, FAIRLAWN NJ 07410
Melissa Rewolinski director 9000 STATE ROAD, PHILADELPHIA PA 19136
Jeffrey Farber officer: Secretary
Samuel H Israel officer: Chief Legal Officer 9000 STATE ROAD, PHILADELPHIA PA 19136
John Abt officer: Vice President of Quality 9000 STATE ROAD, PHILADELPHIA PA 19136
John Kozlowski officer: Chief Operating Officer 9000 STATE ROAD, PHILADELPHIA PA 19136
David A Drabik director 9000 STATE RD, PHILADELPHIA PA 19136
Paul Taveira director 9000 STATE ROAD, PHILADELPHIA PA 19136
Albert Iii Paonessa director 9852 NW 2ND COURT, PLANTATION FL 33324
Kevin Smith other: Vice President
Maureen Cavanaugh officer: Senior Vice President and CCOO 9000 STATE ROAD, PHILADELPHIA PA 19136
David Farber officer: Treasurer
Arthur P Bedrosian officer: President P O BOX D 1400, POMONA NY 10970